ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 1.19 USD Market Closed
Market Cap: 199.7m USD
Have any thoughts about
ATAI Life Sciences NV?
Write Note
ATAI
/
Balance Sheet
/
Long-Term Debt

ATAI Life Sciences NV
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

ATAI Life Sciences NV
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
ATAI Life Sciences NV
NASDAQ:ATAI
Long-Term Debt
$17.9m
CAGR 3-Years
108%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Long-Term Debt
€36.7B
CAGR 3-Years
0%
CAGR 5-Years
-1%
CAGR 10-Years
12%
Merck KGaA
XETRA:MRK
Long-Term Debt
€7.9B
CAGR 3-Years
-1%
CAGR 5-Years
-2%
CAGR 10-Years
14%
MPH Health Care AG
XETRA:93M1
Long-Term Debt
€8.3m
CAGR 3-Years
41%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Long-Term Debt
€904.6m
CAGR 3-Years
16%
CAGR 5-Years
15%
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Long-Term Debt
€65.8m
CAGR 3-Years
669%
CAGR 5-Years
205%
CAGR 10-Years
N/A
No Stocks Found

ATAI Life Sciences NV
Glance View

Market Cap
199.7m USD
Industry
Pharmaceuticals

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company engages in the treatment of mental health disorders. The company is headquartered in Berlin, Berlin and currently employs 81 full-time employees. The company went IPO on 2021-06-18. The firm is aiming to transform the treatment of mental health disorders.

ATAI Intrinsic Value
0.02 USD
Overvaluation 98%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is ATAI Life Sciences NV's Long-Term Debt?
Long-Term Debt
17.9m USD

Based on the financial report for Dec 31, 2023, ATAI Life Sciences NV's Long-Term Debt amounts to 17.9m USD.

What is ATAI Life Sciences NV's Long-Term Debt growth rate?
Long-Term Debt CAGR 3Y
108%

Over the last year, the Long-Term Debt growth was 18%. The average annual Long-Term Debt growth rates for ATAI Life Sciences NV have been 108% over the past three years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.